Alopecia

The largest patient study across the continent found a direct link between the extent of hair loss and the negative impact on quality of life.

A recent study spotlights an opportunity for interdisciplinary collaboration between dermatologists and orthodontists.

This week’s collection of the latest dermatologic studies includes artificial intelligence in cutaneous lesions, dupilumab-induced acanthosis nigricans, aesthetic considerations for treating lesbian, gay, and bisexual patients, and monotherapies for male androgenetic alopecia.

These challenges may exacerbate racial inequities in care access and quality, according to a new study.

Three distinct congresses known as RAVE (Revolutionizing Atopic Dermatitis, Alopecia Areata, and Vitiligo) will be held June 8-10, in Chicago, Illinois.

Explore recent research that shed light on potential associations and manifestations post-COVID-19 infection or vaccination.

The data suggests that the medication, which targets specific cellular pathways, promotes hair regrowth in AA with minimal adverse effects.

Ronda Farah, MD, FAAD, reviews top hair loss pearls from her 5 sessions at AAD 2024.

In this week’s Pointers With Portela, the 208SkinDoc answers common hair loss questions.

The study will evaluate rezpegaldesleukin and its effect on Severity of Alopecia Tool scoring by the conclusion of a 36-week period.

Factors including disease duration, treatment response, and mental health were listed as crucial factors in severity and treatment.